Investors Eye Class Action Against TruBridge Over Accounting Errors
A New York-based law firm is signaling potential legal action against TruBridge, Inc. following revelations that the healthcare services provider issued inaccurate financial statements for multiple years. The investigation focuses on whether shareholders were misled by accounting discrepancies that triggered a sharp decline in the company’s stock price.
The scrutiny centers on a March 17, 2026, regulatory filing where TruBridge admitted it could not submit its annual report on time. The company cited a need to correct errors in previous financial statements dating back to 2023. These adjustments involve revenue recognition, contract costs, stock-based compensation, and software development expenses for fiscal years 2023 and 2024, as well as several quarters in 2025.
Following the disclosure of these accounting irregularities, TruBridge shares dropped 10.5%, or $1.84, closing the trading session at $15.75. Rosen Law Firm is currently soliciting shareholders who purchased stock during the relevant period to join a potential class action lawsuit. The firm, which operates on a contingency fee basis, claims that investors may be eligible for compensation for losses linked to the alleged dissemination of misleading business information.
Comments (0)
No comments yet. Be the first!